ADME
Showing 1 - 25 of 159
Fungal Disease Trial in Nottingham (Ibrexafungerp)
Recruiting
- Fungal Disease
-
Nottingham, United KingdomQuotient Sciences Limited
Dec 20, 2022
Healthy Male Subjects Trial in Shanghai ([14C] Yiqibuvir)
Not yet recruiting
- Healthy Male Subjects
- [14C] Yiqibuvir
-
Shanghai, Shanghai, ChinaShanghai xuhui central hospital
Aug 16, 2023
Sickle Cell Disease Trial in Groningen (GBT021601)
Active, not recruiting
- Sickle Cell Disease
-
Groningen, NetherlandsICON Clinical Research Unit
Jan 30, 2023
Healthy Male Subjects Trial in Shanghai ([14C] Antaitavir Hasophate)
Completed
- Healthy Male Subjects
- [14C] Antaitavir Hasophate
-
Shanghai, Shanghai, ChinaShanghai xuhui central hospital
Jan 4, 2023
NASH With Fibrosis Trial ([14C]-rencofilstat 225mg)
Not yet recruiting
- NASH With Fibrosis
- [14C]-rencofilstat 225mg
- (no location specified)
Feb 21, 2023
Solid Tumors Trial in Budapest ([14C] Subasumstat, Subasumstat)
Not yet recruiting
- Solid Tumors
- [14C] Subasumstat
- Subasumstat
-
Budapest, Hungary
- +1 more
Jul 28, 2023
Healthy Male Subjects Trial in Lincoln (14C RPT193)
Not yet recruiting
- Healthy Male Subjects
- 14C RPT193
-
Lincoln, NebraskaCelerion
Oct 13, 2023
Cardiovascular Diseases Trial in Ruddington (AZD0780 tablet, [14C]AZD0780 Solution for Infusion, [14C]AZD0780 Oral Solution)
Not yet recruiting
- Cardiovascular Diseases
- AZD0780 tablet
- +2 more
-
Ruddington, United KingdomResearch Site
Apr 5, 2023
Asthma Trial in Ruddington (AZD4604 Inhalation Powder, 1 mg, [14C]AZD4604 Solution for Infusion 6 µg/mL (NMT 37.0 kBq/5 mL),
Not yet recruiting
- Asthma
- AZD4604 Inhalation Powder, 1 mg
- +2 more
-
Ruddington, United KingdomQuotient Sciences Limited
Nov 27, 2023
Healthy Trial in Groningen (ACT-777991 (SAD), ACT-777991 (MAD), Placebo (SAD))
Completed
- Healthy
- ACT-777991 (SAD)
- +7 more
-
Groningen, NetherlandsQPS Netherlands B.V.
Jun 17, 2022
Healthy Adult Male Volunteers Trial in Nanjing ([14C]-Larotinib)
Active, not recruiting
- Healthy Adult Male Volunteers
-
Nanjing, Jiangsu, ChinaJiangsu Province Hospital
Mar 9, 2022
Solid Tumors Trial in Budapest ([¹4C]-BI 907828 mixed with BI 907828 (formulation 1), [¹4C]-BI 907828 mixed with BI 907828
Recruiting
- Solid Tumors
- [¹⁴C]-BI 907828 mixed with BI 907828 (formulation 1)
- +2 more
-
Budapest, HungaryPRA Hungary Ltd.
Jan 9, 2023
Healthy Volunteers Trial in Ruddington ([14C]SJP-0008)
Completed
- Healthy Volunteers
-
Ruddington, Nottingham, United KingdomQuotient Sciences
Apr 1, 2022
Healthy Adult Male Volunteers Trial ([14C]- Rongliflozin)
Not yet recruiting
- Healthy Adult Male Volunteers
- [14C]- Rongliflozin
- (no location specified)
Oct 26, 2021
Healthy Adult Male Volunteers Trial in Suzhou ([14C]-Jaktinib)
Recruiting
- Healthy Adult Male Volunteers
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of soochow University
Jan 11, 2022
COPD (COPD) Trial in Lincoln (TD-4208)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
-
Lincoln, NebraskaCelerion
Feb 22, 2022
Cardiovascular Disease Trial in Ruddington (AZD9977 capsule 50 mg, [14C]AZD9977 Solution for Infusion, 20 µg/mL (NMT 37.0 kBq/5
Completed
- Cardiovascular Disease
- AZD9977 capsule 50 mg
- +2 more
-
Ruddington, United KingdomResearch Site
Mar 5, 2021
Healthy Trial in Zuidlaren (IPI-145)
Completed
- Healthy
-
Zuidlaren, NetherlandsPharmaceuticals Research Association (PRA)
Mar 15, 2021
Trypanosomiases, African Trial in Nottingham ([14C]-acoziborole capsule, 240 mg containing NMT 9.25 kBq (250 nCi) 14C)
Completed
- Trypanosomiases, African
- [14C]-acoziborole capsule, 240 mg containing NMT 9.25 kBq (250 nCi) 14C
-
Nottingham, United KingdomQuotient Sciences
Apr 26, 2021
Advanced Solid Malignancies Trial in Amsterdam (TKI258)
Completed
- Advanced Solid Malignancies
-
Amsterdam, NetherlandsNovartis Investigative Site
Dec 17, 2020
Pulmonary Disease, Chronic Obstructive Trial in London ([14C]-GSK961081 solution for IV infusion, [14C]-GSK961081 oral solution,
Completed
- Pulmonary Disease, Chronic Obstructive
- [14C]-GSK961081 solution for IV infusion
- +2 more
-
London, United KingdomGSK Investigational Site
Sep 28, 2021